caffeic acid phenethyl ester has been researched along with dactolisib in 1 studies
Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (dactolisib) | Trials (dactolisib) | Recent Studies (post-2010) (dactolisib) |
---|---|---|---|---|---|
840 | 1 | 469 | 444 | 14 | 405 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Esmaeil, N; Ghatrehsamani, M; Shirzad, H; Soltani, A; Torki, S | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and dactolisib
Article | Year |
---|---|
Synergistic antitumor effect of NVP-BEZ235 and CAPE on MDA-MB-231 breast cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Female; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neoplasm Proteins; Phenylethyl Alcohol; Phosphorylation; Protein Processing, Post-Translational; Quinolines; Receptors, CXCR4; Triple Negative Breast Neoplasms | 2017 |